Tue, Jan 27, 2015, 9:53 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

  • gadder007 gadder007 Jul 18, 2014 4:24 PM Flag

    Gilead: New price target 141 and time for a dividend

    That really should boost stock price over a hundred over the next few days....

    Barrons: "Gilead Sciences: Time For a Dividend?"

    "By Ben Levisohn
    Nomura’s N. Ian Somaiya has a bunch of nice things to say about Gilead Sciences (GILD) yesterday, but the most interesting bit might be his expectation that Gilead initiates a dividend next year:

    We raise our TP on Gilead Sciences to $141, from $130, on strength of prescription data for Sovaldi and our assumptions for peak sales of $22bn (up from $16bn)based on launch of new two-drug and three-drug HCV combos in 2017 and 2018, respectively. We expect Phase I/II data by year end (potentially AASLD Nov 7-11) to confirm their ability to maintain cure rates above 90%, while reducing treatment duration to six weeks. Our revised estimates are based on avg price per patient of $70k, below Sovaldi’s $84k and payor expectations for combination prices of $120-150k. Our revised model strengthens our view that Gilead Sciences is the most attractively priced large-cap growth stock in the healthcare industry, with 2015 P/E of 11.2x. With free cash flow expected to reach ~$8.8bn in 2014 and ~$13bn in 2015, we believe Gilead Sciences will not only continue to aggressively buy back shares but also introduce a dividend in 2015.

    Big biotech stocks have been strong today, and none more so than Gilead Sciences. Its shares have jumped 3.6% to $88.15% at 12:35 p.m. today, while Celgene (CELG) has risen 2.6% to $85.31, Regeneron (REGN) has advanced 2,2% to $302.78, Biogen Idec (BIIB) has gained 1.3% to $303.04 and Amgen (AMGN) is up 2% at 117.65."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
105.03-2.08(-1.94%)Jan 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Horizon Pharma plc
NASDAQTue, Jan 27, 2015 4:00 PM EST
Yahoo! Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST